Literature DB >> 25668448

Inactivating STAT3: bad for tumor, good for muscle.

Rosanna Piccirillo1, Raffaella Giavazzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25668448      PMCID： PMC4613659          DOI： 10.1080/15384101.2015.1010979

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

2.  Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.

Authors:  Liping Zhang; Jenny Pan; Yanjun Dong; David J Tweardy; Yanlan Dong; Giacomo Garibotto; William E Mitch
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

Review 3.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Authors:  Hua Yu; Heehyoung Lee; Andreas Herrmann; Ralf Buettner; Richard Jove
Journal:  Nat Rev Cancer       Date:  2014-11       Impact factor: 60.716

Review 4.  Understanding the mechanisms and treatment options in cancer cachexia.

Authors:  Kenneth Fearon; Jann Arends; Vickie Baracos
Journal:  Nat Rev Clin Oncol       Date:  2012-12-04       Impact factor: 66.675

Review 5.  Muscle wasting in disease: molecular mechanisms and promising therapies.

Authors:  Shenhav Cohen; James A Nathan; Alfred L Goldberg
Journal:  Nat Rev Drug Discov       Date:  2015-01       Impact factor: 84.694

6.  Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.

Authors:  Francesca Pretto; Carmen Ghilardi; Michele Moschetta; Andrea Bassi; Alessandra Rovida; Valentina Scarlato; Laura Talamini; Fabio Fiordaliso; Cinzia Bisighini; Giovanna Damia; Maria Rosa Bani; Rosanna Piccirillo; Raffaella Giavazzi
Journal:  Oncotarget       Date:  2015-02-20

7.  Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3.

Authors:  Míriam Toledo; Fabio Penna; Sílvia Busquets; Francisco J López-Soriano; Josep M Argilés
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240
  7 in total
  5 in total

1.  Diabetes Worsens Skeletal Muscle Mitochondrial Function, Oxidative Stress, and Apoptosis After Lower-Limb Ischemia-Reperfusion: Implication of the RISK and SAFE Pathways?

Authors:  Julien Pottecher; Chris Adamopoulos; Anne Lejay; Jamal Bouitbir; Anne-Laure Charles; Alain Meyer; Mervyn Singer; Valerie Wolff; Pierre Diemunsch; Gilles Laverny; Daniel Metzger; Bernard Geny
Journal:  Front Physiol       Date:  2018-05-22       Impact factor: 4.566

2.  Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease.

Authors:  Laura Pasetto; Davide Olivari; Giovanni Nardo; Maria Chiara Trolese; Caterina Bendotti; Rosanna Piccirillo; Valentina Bonetto
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

Review 3.  STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases.

Authors:  Stella Logotheti; Brigitte M Pützer
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639

4.  Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling.

Authors:  Xiao-Long Lin; Mihua Liu; Yuanbo Liu; Huijun Hu; Yongquan Pan; Weiwen Zou; Xiaojuan Fan; Xuemei Hu
Journal:  Int J Mol Med       Date:  2017-11-01       Impact factor: 4.101

Review 5.  TRIM32: A Multifunctional Protein Involved in Muscle Homeostasis, Glucose Metabolism, and Tumorigenesis.

Authors:  Simranjot Bawa; Rosanna Piccirillo; Erika R Geisbrecht
Journal:  Biomolecules       Date:  2021-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.